SCI Pharmtech Corp. Statistics
SCI Pharmtech Corp. (4119) Stock Statistics & Valuation Metrics
Total Valuation
SCI Pharmtech Corp. has a market cap or net worth of TWD 5.92B. The enterprise value is TWD 6.33B.
- Market Cap
- TWD 5.92B
- Enterprise Value
- TWD 6.33B
Share Statistics
SCI Pharmtech Corp. has 119,508,640 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 119,508,640
- Owned by Insiders
- ―
- Owned by Institutions
- 0.09%
Financial Efficiency
SCI Pharmtech Corp.’s return on equity (ROE) is 0.02 and return on invested capital (ROIC) is 2.38%.
- Return on Equity (ROE)
- 0.02
- Return on Assets (ROA)
- 0.02
- Return on Invested Capital (ROIC)
- 2.38%
- Return on Capital Employed (ROCE)
- 0.03
- Revenue Per Employee
- 6.65M
- Profits Per Employee
- 531.55K
- Employee Count
- 202
- Asset Turnover
- 0.20
- Inventory Turnover
- 1.41
Valuation Ratios
The current PE Ratio of SCI Pharmtech Corp. is 99.61. SCI Pharmtech Corp.’s PEG ratio is -1.14.
- PE Ratio
- 99.61
- PS Ratio
- 4.82
- PB Ratio
- 1.14
- Price to FCF
- -34.80
- Price to Operating Cash Flow
- 27.12
- PEG Ratio
- -1.14
Income Statement
In the last 12 months, SCI Pharmtech Corp. had revenue of 1.34B and earned 107.37M in profits. Earnings per share was 0.90.
- Revenue
- 1.34B
- Gross Profit
- 319.47M
- Operating Income
- 155.25M
- Pretax Income
- 102.19M
- Net Income
- 107.37M
- EBITDA
- 408.21M
- Earnings Per Share (EPS)
- 0.90
Cash Flow
In the last 12 months, operating cash flow was 223.88M and capital expenditures -398.32M, giving a free cash flow of -174.44M billion.
- Operating Cash Flow
- 223.88M
- Free Cash Flow
- -174.44M
- Free Cash Flow per Share
- -1.46
Dividends & Yields
SCI Pharmtech Corp. pays an annual dividend of ―, resulting in a dividend yield of 1.51%
- Dividend Per Share
- ―
- Dividend Yield
- 1.51%
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -2.87%
- Earnings Yield
- 0.99%
Stock Price Statistics
- Beta
- 0.30
- 52-Week Price Change
- -13.07%
- 50-Day Moving Average
- 54.85
- 200-Day Moving Average
- 49.64
- Relative Strength Index (RSI)
- 32.42
- Average Volume (3m)
- 174.57K
Important Dates
SCI Pharmtech Corp. upcoming earnings date is Mar 16, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Nov 06, 2026
- Next Earnings Date
- Mar 16, 2027
- Ex-Dividend Date
- ―
Financial Position
SCI Pharmtech Corp. as a current ratio of 1.05, with Debt / Equity ratio of 18.30%
- Current Ratio
- 1.05
- Quick Ratio
- 0.35
- Debt to Market Cap
- 0.16
- Net Debt to EBITDA
- 2.27
- Interest Coverage Ratio
- 31.45
Taxes
In the past 12 months, SCI Pharmtech Corp. has paid -5.18M in taxes.
- Income Tax
- -5.18M
- Effective Tax Rate
- -0.05
Enterprise Valuation
SCI Pharmtech Corp. EV to EBITDA ratio is 19.57, with an EV/FCF ratio of -40.41.
- EV to Sales
- 5.59
- EV to EBITDA
- 19.57
- EV to Free Cash Flow
- -40.41
- EV to Operating Cash Flow
- 31.48
Balance Sheet
SCI Pharmtech Corp. has TWD 84.07M in cash and marketable securities with TWD 1.06B in debt, giving a net cash position of -TWD 976.75M billion.
- Cash & Marketable Securities
- TWD 84.07M
- Total Debt
- TWD 1.06B
- Net Cash
- -TWD 976.75M
- Net Cash Per Share
- -TWD 8.17
- Tangible Book Value Per Share
- TWD 44.22
Margins
Gross margin is 22.29%, with operating margin of 8.25%, and net profit margin of 4.77%.
- Gross Margin
- 22.29%
- Operating Margin
- 8.25%
- Pretax Margin
- 6.04%
- Net Profit Margin
- 4.77%
- EBITDA Margin
- 28.58%
- EBIT Margin
- 8.27%
Analyst Forecast
The average price target for SCI Pharmtech Corp. is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- -18.83%
- EPS Growth Forecast
- -87.54%
